Skip to content
HowShorted

SOLENO THERAPEUTICS INC short interest in 2023

In 2023, SOLENO THERAPEUTICS INC's disclosed short interest ran from 2.26% of shares outstanding on 31 Jan 2023 to 4.40% on 29 Dec 2023, a change of +2.14 percentage points. The year's high was 4.40% on 29 Dec 2023 and its low 0.76% on 28 Apr 2023, averaging 1.46% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 5.02 days on 29 Dec 2023. Full history: SOLENO THERAPEUTICS INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for SOLENO THERAPEUTICS INC in 2023

2023 in figures

Start of year
2.26% (31 Jan 2023)
End of year
4.40% (29 Dec 2023)
Change
+2.14 pp
High
4.40% (29 Dec 2023)
Low
0.76% (28 Apr 2023)
Average
1.46%
Highest days to cover
5.02 (29 Dec 2023)
SEC filings marked
7

Every report in 2023

SOLENO THERAPEUTICS INC short interest in 2023
SettlementShort interestDays to coverFilings since previous
31 Jan 20232.26%1.17
15 Feb 20231.35%1.30
28 Feb 20231.34%3.26
15 Mar 20231.12%2.12
31 Mar 20231.04%3.92results (8-K), 10-K filed
14 Apr 20231.32%1.29
28 Apr 20230.76%1.22
15 May 20230.87%1.0010-Q filed, results (8-K)
31 May 20231.21%1.00
15 Jun 20231.10%1.00
30 Jun 20230.89%1.02
14 Jul 20231.01%2.05
31 Jul 20230.88%2.56
15 Aug 20230.82%2.8210-Q filed, results (8-K)
31 Aug 20230.80%1.00
15 Nov 20231.90%2.3310-Q filed
30 Nov 20232.24%2.98
15 Dec 20232.48%1.21
29 Dec 20234.40%5.02

See also: SOLENO THERAPEUTICS INC's full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.